349 related articles for article (PubMed ID: 25931821)
1. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
2. A Novel Biomolecule-Mediated Reduction of Graphene Oxide: A Multifunctional Anti-Cancer Agent.
Choi YJ; Kim E; Han J; Kim JH; Gurunathan S
Molecules; 2016 Mar; 21(3):375. PubMed ID: 26999102
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
4. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
Gurunathan S; Han J; Park JH; Kim JH
Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
6. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells.
Gurunathan S; Han JW; Eppakayala V; Kim JH
Int J Nanomedicine; 2013; 8():1015-27. PubMed ID: 23687445
[TBL] [Abstract][Full Text] [Related]
7. Differential Immunomodulatory Effect of Graphene Oxide and Vanillin-Functionalized Graphene Oxide Nanoparticles in Human Acute Monocytic Leukemia Cell Line (THP-1).
Gurunathan S; Kang MH; Jeyaraj M; Kim JH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634552
[TBL] [Abstract][Full Text] [Related]
8. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study.
Reshma SC; Syama S; Mohanan PV
Colloids Surf B Biointerfaces; 2016 Apr; 140():104-116. PubMed ID: 26741270
[TBL] [Abstract][Full Text] [Related]
9. Green chemistry approach for the synthesis of biocompatible graphene.
Gurunathan S; Han JW; Kim JH
Int J Nanomedicine; 2013; 8():2719-32. PubMed ID: 23940417
[TBL] [Abstract][Full Text] [Related]
10. Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.
Yuan YG; Wang YH; Xing HH; Gurunathan S
Int J Nanomedicine; 2017; 12():5819-5839. PubMed ID: 28860751
[TBL] [Abstract][Full Text] [Related]
11. Acoustic cavitation induced generation of stabilizer-free, extremely stable reduced graphene oxide nanodispersion for efficient delivery of paclitaxel in cancer cells.
Geetha Bai R; Muthoosamy K; Shipton FN; Manickam S
Ultrason Sonochem; 2017 May; 36():129-138. PubMed ID: 28069192
[TBL] [Abstract][Full Text] [Related]
12. Intracellular localization and toxicity of graphene oxide and reduced graphene oxide nanoplatelets to mussel hemocytes in vitro.
Katsumiti A; Tomovska R; Cajaraville MP
Aquat Toxicol; 2017 Jul; 188():138-147. PubMed ID: 28521151
[TBL] [Abstract][Full Text] [Related]
13. Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial.
Zhang XF; Gurunathan S
Int J Nanomedicine; 2016; 11():6635-6649. PubMed ID: 27994461
[TBL] [Abstract][Full Text] [Related]
14. An environmentally friendly approach to the reduction of graphene oxide by Escherichia fergusoni.
Gurunathan S; Han JW; Eppakayala V; Jeyaraj M; Kim JH
J Nanosci Nanotechnol; 2013 Mar; 13(3):2091-8. PubMed ID: 23755651
[TBL] [Abstract][Full Text] [Related]
15. A Simple Route to the Complexation of Lutein with Reduced Graphene Oxide Nanocarriers and Antioxidant Protection Against Blue Light.
Chae SY; Shin MC; Jeon S; Kang MS; Han DW; Hong SW
Int J Nanomedicine; 2021; 16():6843-6860. PubMed ID: 34675511
[TBL] [Abstract][Full Text] [Related]
16. Enhanced green fluorescent protein-mediated synthesis of biocompatible graphene.
Gurunathan S; Woong Han J; Kim E; Kwon DN; Park JK; Kim JH
J Nanobiotechnology; 2014 Oct; 12():41. PubMed ID: 25273520
[TBL] [Abstract][Full Text] [Related]
17. Graphene-based antibacterial paper.
Hu W; Peng C; Luo W; Lv M; Li X; Li D; Huang Q; Fan C
ACS Nano; 2010 Jul; 4(7):4317-23. PubMed ID: 20593851
[TBL] [Abstract][Full Text] [Related]
18. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
19. Production of Reduced Graphene Oxide by Using Three Different Microorganisms and Investigation of Their Cell Interactions.
Utkan G; Yumusak G; Tunali BC; Ozturk T; Turk M
ACS Omega; 2023 Aug; 8(34):31188-31200. PubMed ID: 37663476
[TBL] [Abstract][Full Text] [Related]
20. Graphene oxide and reduced graphene oxide induced neural pheochromocytoma-derived PC12 cell lines apoptosis and cell cycle alterations via the ERK signaling pathways.
Kang Y; Liu J; Wu J; Yin Q; Liang H; Chen A; Shao L
Int J Nanomedicine; 2017; 12():5501-5510. PubMed ID: 28814866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
